Nobuhiro Nakazawa, Makoto Sohda, Munenori Ide, Yuki Shimoda, Akihiko Sano, Makoto Sakai, Tetsunari Oyama, Ken Shirabe, Hiroshi Saeki. Poorly cohesive gastric cancer with increased epithelial-mesenchymal transition is associated with a poor prognosis. Oncology letters. 2024. 28. 3. 420-420
Makoto Sakai, Makoto Sohda, Shintaro Uchida, Arisa Yamaguchi, Takayoshi Watanabe, Hideyuki Saito, Yasunari Ubukata, Nobuhiro Nakazawa, Kengo Kuriyama, Akihiko Sano, et al. Reply to: "Predictive Role of Age-Adjusted Charlson Comorbidity Index for Long-Term Survival in Surgical Esophageal Cancer Patients," by Yuan, Yong et al. Annals of surgical oncology. 2024. 31. 8. 5101-5101
Natsumi Mori, Gendensuren Dorjkhorloo, Takuya Shiraishi, Bilguun Erkhem-Ochir, Haruka Okami, Arisa Yamaguchi, Ikuma Shioi, Chika Komine, Mizuki Endo, Takaomi Seki, et al. A Mature Tertiary Lymphoid Structure with a Ki-67-Positive Proliferating Germinal Center Is Associated with a Good Prognosis and High Intratumoral Immune Cell Infiltration in Advanced Colorectal Cancer. Cancers. 2024. 16. 15
Nobuhiro Nakazawa, Makoto Sohda, Mizuki Endo, Nobuhiro Hosoi, Shintaro Uchida, Takayoshi Watanabe, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Ken Shirabe, et al. The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients. Cancer chemotherapy and pharmacology. 2024
Ikuma Shioi, Hiroomi Ogawa, Ryozan Naito, Mizuki Endo, Nobuhiro Hosoi, Kohei Tateno, Shintaro Uchida, Arisa Yamaguchi, Takayoshi Watanabe, Nobuhiro Nakazawa, et al. Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Anticancer research. 2024. 44. 7. 3013-3023
